Hi ,
We hope this finds you well and enjoying the advent of fall weather. Here in Boulder, CO the leaves are brilliantly yellow/orange/red, apples and pears cover our grounds, and the Rocky Mountains behind us are all covered with early snow.
As we look forward to winter and the prospect of holidays spent with loved ones, I would like to highlight the fact that shortly thereafter, we at SynBioBeta will stage the SynBio industry’s premier networking event on Jan 25-27 in Oakland, CA. Please plan to join us for three days of greeting, meeting, and collaborating with both old friends and a host of newcomers, all working together to change the world through biology.
As a limited time benefit, SynBioBeta’s exclusive lodging partner, the Oakland Marriott City Center, is providing outstanding room rates for conference attendees. Please click here for further details. Don’t delay, as these discounted rates expire on November 30, 2021.
Have a great week, enjoy the news below, and look forward to seeing you all in January.
Larry
|
 |
Larry Upton
Editor in Chief
larry.upton@synbiobeta.com
|
|
|
|
|
 |
Spotlight on: Cemvicta Factory |
Heavy industries like mining and chemical manufacturing are critical to modern life. But they are highly polluting and extremely difficult to decarbonize. Meet Cemvita Factory, the company using microbes to turn industrial emissions into valuable products! One of the coolest things the company does is to optimize microbes for mining. Did you know microbes can separate valuable metals from rocks more effectively—and safely! —than the typical chemicals that make mining so polluting? Cemvita’s work is helping keep toxins away from our environment and out of our atmosphere! Learn more about Cemvita’s work here!
|
|
|
|
 |
Spotlight on: Culture Biosciences |
Did you know that bioreactors can range in size from a water bottle to an entire building? Culture Biosciences is building bioreactors that can carry out biological reactions for everything from new therapeutics to alternative meat proteins. Its 250mL bioreactors are about the size of a water bottle but give researchers a powerful way to test their products before scaling to manufacturing. Culture is also building 5L and 250L bioreactors to help companies scale their products for the commercial market. Having the right infrastructure to make bioproducts is crucial for companies that care about the environment and want to reduce global dependence on petrochemicals. Learn more about Culture’s work!
|
|
|
|
 |
Spotlight on: bit.bio |
Did you know mice don't get Alzheimer's? So why do we use them to test Alzheimer's drugs? Typically, human cell cultures, including brain cells, are very difficult to obtain for medical research. But now, the UK-based cell engineering company, bit.bio, has developed a breakthrough technology that can turn one type of cell into another using molecular switches called transcription factors. This innovation could help advance Alzheimer's research, cell therapy, and maybe in the future, blood cells for blood banks! The company is also discovering which transcription factors program which cell types – check out their latest cell type launch here!
|
|
|
|
|
|
|
 |
How Culture Biosciences is meeting the demand for large-scale biomanufacturing |
Culture Biosciences, a technology company that offers an easier, faster, and cheaper way to do biomanufacturing R&D, announced a Series B financing of $80 million.
|
Keep Reading »
|
|
 |
Volta Labs: Improving workflows for genetic applications |
"Our technology is a small-scale, benchtop device that is low-cost and has minimal consumable usage, enabling rapid and flexible composition of new biological workflows"
|
Keep Reading »
|
|
|
 |
Synthetic biology moves into the realm of the unnatural |
Technology opens up possibilities for fuels with desirable properties that can be produced renewably, as well as new antibiotics, and new nutraceuticals.
|
Keep Reading »
|
|
|
 |
Chemicals & Materials Digital Conference
|
November 17th, 2021
|
$49.99 for digital conference only.
FREE to all SynBioBeta live conference ticket holders.
|
Register Now »
|
|
|
|
|
Locus Biosciences secures up to $25M to develop a new class of precision engineered bacteriophage treatments
|
Keep Reading »
|
|
|
Book review: Synthetic biology — a call to meddle better
|
Keep Reading »
|
|
|
Origin.bio and Carbocycle join forces to revolutionize the chemical industry towards a regenerative future
|
Keep Reading »
|
|
|
|
|
SOSV’s IndieBio — New York’s latest launch pad for early-stage biotech
|
Keep Reading »
|
|
|
AgTech startup Pivot Bio moves into CPG space with Connect popcorn
|
Keep
Reading »
|
|
|
Cellibre closes a bridge financing to accelerate the production of pure, natural, pharmaceutical-grade cannabinoids via fermentation
|
Keep Reading »
|
|
|
Synlogic announces Nature publication demonstrating novel application of synthetic biotic platform
|
Keep Reading »
|
|
|
|
|
